Chronic cough, defined as a persistent cough lasting more than eight weeks, is a common clinical issue that often poses diagnostic and therapeutic challenges. The condition can significantly impact the quality of life, leading to physical discomfort, social embarrassment, and psychological distress. This article aims to provide a comprehensive approach to diagnosing and managing chronic cough in clinical practice.
Effective management of chronic cough begins with a thorough clinical evaluation. It is crucial to consider the patient's medical history, physical examination findings, and exposure history. The most common causes include upper airway cough syndrome (UACS), gastroesophageal reflux disease (GERD), and non-asthmatic eosinophilic bronchitis (NAEB). However, 'unexplained' chronic cough remains a significant subset, warranting further investigation.
Diagnostic testing is an integral part of the evaluation process. Pulmonary function tests, chest radiographs, and CT scans can help identify structural abnormalities and assess lung function. In cases where common causes are ruled out, more advanced tests like bronchoscopy, esophageal pH monitoring, and laryngoscopy may be necessary.
Treatment should be tailored according to the underlying cause. For UACS, antihistamines and nasal steroids may be beneficial. GERD-related cough may respond to proton pump inhibitors, while inhaled corticosteroids are the mainstay of treatment for NAEB. In refractory cases, non-pharmacological approaches like speech therapy and behavioral therapy may prove beneficial.
Chronic cough is a multifactorial condition that requires a systematic and comprehensive approach for effective diagnosis and management. Understanding the potential causes and appropriate diagnostic tests is vital. Tailored treatment strategies can significantly improve patient outcomes and quality of life. Continued research and clinical innovation are needed to further unravel the mystery of chronic cough.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation